ATE534750T1 - Onkofetales fibronektin als zervixkarzinom-marker - Google Patents

Onkofetales fibronektin als zervixkarzinom-marker

Info

Publication number
ATE534750T1
ATE534750T1 AT05810341T AT05810341T ATE534750T1 AT E534750 T1 ATE534750 T1 AT E534750T1 AT 05810341 T AT05810341 T AT 05810341T AT 05810341 T AT05810341 T AT 05810341T AT E534750 T1 ATE534750 T1 AT E534750T1
Authority
AT
Austria
Prior art keywords
oncofetal fibronectin
sample
amount
indicating molecule
classifying
Prior art date
Application number
AT05810341T
Other languages
English (en)
Inventor
Robert Hussa
Mark Fischer-Colbrie
Jerome Lapointe
Durlin Hickok
Simon Shorter
Andrew Senyei
Original Assignee
Adeza Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adeza Biomedical Corp filed Critical Adeza Biomedical Corp
Application granted granted Critical
Publication of ATE534750T1 publication Critical patent/ATE534750T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5757—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofoetal proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
AT05810341T 2004-07-30 2005-07-29 Onkofetales fibronektin als zervixkarzinom-marker ATE534750T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US59282304P 2004-07-30 2004-07-30
US59280304P 2004-07-30 2004-07-30
US59282404P 2004-07-30 2004-07-30
US59282504P 2004-07-30 2004-07-30
US59280404P 2004-07-30 2004-07-30
PCT/US2005/027183 WO2006026020A2 (en) 2004-07-30 2005-07-29 Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin

Publications (1)

Publication Number Publication Date
ATE534750T1 true ATE534750T1 (de) 2011-12-15

Family

ID=35841972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05810341T ATE534750T1 (de) 2004-07-30 2005-07-29 Onkofetales fibronektin als zervixkarzinom-marker

Country Status (9)

Country Link
US (8) US20060024757A1 (de)
EP (2) EP1778874B1 (de)
JP (2) JP2008514900A (de)
AT (1) ATE534750T1 (de)
AU (2) AU2005280528B2 (de)
CA (1) CA2575675A1 (de)
DK (1) DK2299275T3 (de)
NZ (1) NZ582466A (de)
WO (1) WO2006026020A2 (de)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060286602A1 (en) * 2004-05-10 2006-12-21 Harald Mischak Method and markers for the diagnosis of renal diseases
JP2008514900A (ja) * 2004-07-30 2008-05-08 アデザ・バイオメデイカル・コーポレイシヨン 疾病および他の状態のマーカーとしての癌胎児性フィブロネクチンならびに癌胎児性フィブロネクチンの検出のための方法
JP4306607B2 (ja) * 2004-12-24 2009-08-05 富士ゼロックス株式会社 電界効果トランジスタ
US20060239398A1 (en) * 2005-03-07 2006-10-26 Fused Multimodality Imaging, Ltd. Breast diagnostic apparatus for fused SPECT, PET, x-ray CT, and optical surface imaging of breast cancer
ES2291071B1 (es) * 2005-06-13 2009-03-16 Proyecto De Biomedicina Cima, S.L. Agentes y metodos basados en el uso del dominio eda de la fibronectina.
US20070015166A1 (en) * 2005-07-14 2007-01-18 Nilsen Thor W Lateral flow methods and devices for detection of nucleic acid binding proteins
WO2007127392A2 (en) * 2006-04-27 2007-11-08 Pronovost Allan D Devices and methods for collecting oral samples of enriched serous fluid
US20080108097A1 (en) * 2006-07-24 2008-05-08 National Institute Of Advanced Industrial Science And Technology Method for producing complex of biotin-labeled cypridina (cypridina noctiluca) luciferase with streptoavidin and method for stabilizing the same
BRPI0717416A2 (pt) 2006-09-21 2013-11-12 Prometheus Lab Inc Método para realizar um imunoensaio complexo de alta produtividade, e, arranjo
WO2008046510A1 (en) * 2006-10-16 2008-04-24 Bayer Healthcare Ag Fn1 as a biomarker, therapeutic and diagnostic target
JP5351773B2 (ja) * 2007-03-07 2013-11-27 モザイクヴェス ディアグノシュティクス アンド テラポイティクス アクチェン ゲゼルシャフト 尿試料中の検体の濃度を正規化するための方法
EP1972940A1 (de) * 2007-03-14 2008-09-24 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Nierenerkrankungen
US20080241865A1 (en) * 2007-03-26 2008-10-02 National Institute Of Advanced Industrial Science And Technology Visible to near-infrared light probe comprising complex of cypridina luciferase and quantum dot
WO2008120101A2 (en) 2007-04-02 2008-10-09 Philogen S.P.A. The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases
EP2179291B1 (de) * 2007-07-13 2014-10-22 Nestec S.A. Arzneistoffauswahl für die lungenkrebstherapie unter verwendung von arrays auf antikörperbasis
US7964843B2 (en) 2008-07-18 2011-06-21 The George Washington University Three-dimensional molecular imaging by infrared laser ablation electrospray ionization mass spectrometry
US8067730B2 (en) 2007-07-20 2011-11-29 The George Washington University Laser ablation electrospray ionization (LAESI) for atmospheric pressure, In vivo, and imaging mass spectrometry
US8901487B2 (en) 2007-07-20 2014-12-02 George Washington University Subcellular analysis by laser ablation electrospray ionization mass spectrometry
US10202442B2 (en) 2007-07-25 2019-02-12 Philogen S.P.A. Antigen associated with lung cancers and lymphomas
EP2167541B1 (de) * 2007-07-25 2012-12-19 Philogen S.p.A. Das fibronektin ed-a-antigen ist mit der neovaskulatur von tumormetastasen assoziiert
WO2009047280A2 (de) * 2007-10-09 2009-04-16 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnose von prostatakrebs
EP2051078A1 (de) * 2007-10-19 2009-04-22 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Diabetes Mellitus
AU2014274545B2 (en) * 2007-10-30 2016-10-13 Philogen S.P.A An antigen associated with rheumatoid arthritis
DK3281952T3 (da) 2007-10-30 2020-08-03 Philogen Spa Antigen, der er forbundet med reumatoid artritis
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
AU2009219437B2 (en) * 2008-02-25 2014-10-16 Nestec S.A. Drug selection for breast cancer therapy using antibody-based arrays
JP2011515672A (ja) * 2008-03-19 2011-05-19 モザイクス ダイアグノスティクス アンド セラピューティクス アーゲー 腎尿細管の損傷および疾患の診断のための方法およびマーカー
WO2009128956A1 (en) * 2008-04-18 2009-10-22 University Of Utah Research Foundation Use of a steroid profile in ovarian follicular fluid for diagnosis, prognosis and determining strategies for treatment
JP5084597B2 (ja) * 2008-04-24 2012-11-28 キヤノン株式会社 質量分析基板及び質量分析方法
US20110214990A1 (en) * 2008-09-17 2011-09-08 Mosaiques Diagnostics And Therapeutics Ag Kidney cell carcinoma
DE102008053503B4 (de) * 2008-10-28 2011-04-28 Justus-Liebig-Universität Giessen Immunologischer Test zum Nachweis von Autoantikörpern gegen testikuläre Antigene
CA2747154C (en) 2008-12-19 2015-11-10 Philogen S.P.A. Immunocytokines for tumour therapy with chemotherapeutic agents
CA2748401C (en) 2009-01-07 2017-09-12 Philogen S.P.A. Antigens associated with endometriosis
US20110044963A1 (en) * 2009-03-09 2011-02-24 Puschett Jules B Method of Testing a Patient for Hypertension and Related Method of Treatment and Test Kit
GB0906643D0 (en) 2009-04-17 2009-06-03 Wilson Stuart M Detection of bacteria and fungi
JP5795311B2 (ja) 2009-07-15 2015-10-14 ネステク ソシエテ アノニム 抗体ベースのアレイを使用する胃癌療法のための薬物選択
EP2461832B1 (de) 2009-08-05 2017-06-28 Philogen S.p.A. Abzielung auf die neovaskulatur des knochenmarks
WO2011112993A2 (en) * 2010-03-11 2011-09-15 University Of Louisville Research Foundation, Inc. Methods of predicting and decreasing the risk of pregnancy loss
CN102309809B (zh) * 2010-07-09 2013-11-20 同济大学 造口术系统
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
EP2596132A4 (de) 2010-07-23 2013-12-18 Harvard College Verfahren zur erkennung von anzeichen für krankheiten oder leiden in körperflüssigkeiten
BR112013007311A2 (pt) * 2010-10-01 2016-07-05 Hologic Inc tira de teste de imunoensaio para uso em um sistema de diagnóstico
WO2012058463A2 (en) * 2010-10-27 2012-05-03 Dignity Health Trimegestone (tmg) for treatment of preterm birth
WO2012075318A2 (en) * 2010-12-01 2012-06-07 Cell Signaling Technology, Inc. Fn1 and alk gene translocations in cancer and alk kinase expression in ovarian cancer
JP5947533B2 (ja) * 2011-01-19 2016-07-06 キヤノン株式会社 情報取得方法
US9719995B2 (en) 2011-02-03 2017-08-01 Pierian Holdings, Inc. Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling
FR2976587B1 (fr) * 2011-06-20 2015-04-03 Basf Beauty Care Solutions F Methode de dosage in vitro par technique immunologique
KR101188355B1 (ko) 2011-06-24 2012-10-08 광주과학기술원 알부민 용액을 사용하는 미세부품의 분리방법
IL214096A (en) * 2011-07-14 2016-02-29 Gideon Mor A system for detecting meconium in amniotic fluid
JP2014524121A (ja) 2011-07-14 2014-09-18 ザ・ジョージ・ワシントン・ユニバーシティ レーザアブレーション・エレクトロスプレイイオン化質量分析用のプルームコリメーション
EP2749882B1 (de) * 2011-08-24 2017-05-03 Eiken Kagaku Kabushiki Kaisha Leukozytenmessvorrichtung und reagenzienkit
EP2751562B1 (de) 2011-09-02 2015-09-16 Nestec S.A. Profilierung von signalwegproteinen zur bestimmung der therapeutischen wirksamkeit
US8852873B2 (en) * 2012-04-13 2014-10-07 Diabetomics, Llc Maternal biomarkers for gestational diabetes
EP2836843B1 (de) * 2012-04-13 2020-07-08 Prediction Biosciences S.A.S. Schnelltest für zelluläres fibronectin
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ， 疾患または状態を検出する方法
WO2014051141A1 (ja) * 2012-09-28 2014-04-03 積水メディカル株式会社 無希釈系イムノクロマトグラフ法試薬において希釈試料を測定するための添加物
ES2743423T3 (es) 2012-10-03 2020-02-19 Philogen Spa Conjugado de anticuerpos para su uso en el tratamiento de una enfermedad inflamatoria intestinal
CA2888746C (en) 2012-10-19 2022-07-26 Wayne State University Identification and analysis of fetal trophoblast cells in cervical mucus for prenatal diagnosis
ES2690782T3 (es) 2012-10-24 2018-11-22 Nyu Winthrop Hospital Biomarcador no invasivo para identificar sujetos en riesgo de parto prematuro
US20140227690A1 (en) * 2013-02-08 2014-08-14 St. John Heallth Methods and compositions for assessment of fetal lung maturity
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
EP3004879A4 (de) * 2013-06-04 2017-01-11 Proteometech Inc. Streifen für schnelle tests mit einer variablen steuerleitung und diagnosekit damit
CN106170496B (zh) * 2013-12-12 2019-10-08 Umc乌得勒支控股有限公司 针对纤连蛋白-eda的免疫球蛋白样分子
CN103743911B (zh) * 2013-12-31 2016-01-20 浙江爱康生物科技有限公司 一种纤维连接蛋白测定试剂盒及其制备方法
EP2955517A1 (de) * 2014-06-10 2015-12-16 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Stabilisierung von Körperflüssigkeitsproben durch die Zugabe von Detergenz
US20160025737A1 (en) * 2014-07-25 2016-01-28 Diabetomics, Llc Biomarkers for assessment of preeclampsia
WO2016022597A1 (en) * 2014-08-04 2016-02-11 Case Western Reserve University Targeting peptides and methods of use
US10925980B2 (en) 2014-08-04 2021-02-23 Case Western Reserve University Molecular probes and methods of use
GB2543728B (en) 2014-08-12 2019-04-17 Nextgen Jane Inc Medical kit and method for processing a biological sample
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
WO2016057993A1 (en) * 2014-10-10 2016-04-14 Wayne State University Methods and compositions relating to assays of fetal extravillous trophoblast cells
CN104965014B (zh) * 2015-07-06 2017-06-23 济南大学 用于检测sam的量子点/酶复合碳糊电极的制备方法
WO2017084017A1 (zh) * 2015-11-16 2017-05-26 合肥立方制药股份有限公司 Ed-b蛋白在诊断组织增生中的应用
EP3387430A4 (de) * 2015-12-11 2019-08-14 Expression Pathology, Inc. Srm/mrm-tests
WO2017106769A1 (en) * 2015-12-17 2017-06-22 Polymer Technology Systems, Inc. Systems and methods for point-of-care hdl and ldl particle assay
US20190056390A1 (en) * 2016-02-24 2019-02-21 Sekisui Medical Co., Ltd. Method for detecting oncofetal fibronectin using immunochromatography
WO2017170824A1 (ja) * 2016-03-31 2017-10-05 積水メディカル株式会社 簡易免疫測定を利用した癌胎児性フィブロネクチンの検出方法
US10808239B2 (en) 2016-04-06 2020-10-20 Wayne State University Isolation and analysis of fetal DNA from extravillous trophoblast cells retrieved from the endocervical canal
WO2017180909A1 (en) 2016-04-13 2017-10-19 Nextgen Jane, Inc. Sample collection and preservation devices, systems and methods
US10191046B2 (en) * 2016-05-23 2019-01-29 Se-Hwan Paek Immunobiosensor and sensor system including the same
GB2552195A (en) * 2016-07-13 2018-01-17 Univ Oxford Innovation Ltd Interferometric scattering microscopy
CN107330263B (zh) * 2017-06-26 2020-07-28 成都知识视觉科技有限公司 一种计算机辅助乳腺浸润性导管癌组织学分级的方法
CA3075688A1 (en) 2017-09-13 2019-03-21 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
US12121687B2 (en) 2017-09-18 2024-10-22 North Carolina State University Nanocellulose and nanocellulose composite arrays and devices and methods of making and using the same
US20210093234A1 (en) * 2017-12-11 2021-04-01 Stc.Unm Mild Traumatic Brain Injury Diagnostic Immunochromatographic Microneedle Patch
WO2020081956A1 (en) * 2018-10-18 2020-04-23 Medimmune, Llc Methods for determining treatment for cancer patients
WO2020097499A1 (en) * 2018-11-08 2020-05-14 Michel Lea Diagnosing sepsis or bacteremia by detecting peptidoglycan associated lipoprotein (pal) in urine
WO2021041874A1 (en) 2019-08-29 2021-03-04 Martin David C Biofunctional thiophene monomers
CN111235270B (zh) * 2019-08-29 2022-04-29 北京臻知医学科技有限责任公司 一种基于高通量测序法的肿瘤抗原表达检测引物及试剂盒
BR112022006282A8 (pt) * 2019-10-04 2023-03-21 Vytelle Llc Composições, métodos e kits para seleção de doadores e receptores para fertilização in vitro
GB2588378A (en) 2019-10-10 2021-04-28 Refeyn Ltd Methods and apparatus for optimised interferometric scattering microscopy
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor
DE202020102472U1 (de) * 2020-05-04 2020-12-09 Disphar International Bv Orale Form von Mifepriston zur Verwendung bei Zervixreifung und Geburtseinleitung
CN111751356B (zh) * 2020-07-22 2022-05-24 攀钢集团研究院有限公司 同时测定Fe-EDTA络合脱硝溶液中二价与三价铁离子浓度分量的方法
CN111751355B (zh) * 2020-07-22 2022-05-24 攀钢集团研究院有限公司 测定Fe(Ⅱ)-EDTA络合脱硝液中二价铁离子含量的方法
CN111751357B (zh) * 2020-07-22 2022-05-24 攀钢集团研究院有限公司 测定EDTA络合脱硝液中多形态铁离子共存体系下Fe2+与Fe3+含量的方法
JP7635480B2 (ja) * 2020-11-27 2025-02-26 大王製紙株式会社 Ｒｆｉｄタグ、採血管、及びアンテナ
JPWO2023032925A1 (de) * 2021-08-30 2023-03-09
AU2023232023A1 (en) * 2022-03-08 2024-09-26 Aeena Dx, Inc. Devices for disease detection
US12435357B2 (en) 2022-12-22 2025-10-07 Kanso Diagnostics Ltd. Diagnostic device for detecting a target nucleic acid molecule in a biological sample

Family Cites Families (203)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US522344A (en) * 1894-07-03 John f
US477718A (en) * 1892-06-28 Elevated track or tramway
US477128A (en) * 1892-06-14 lantz
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US1947171A (en) 1931-05-01 1934-02-13 Prussing Walter Tube making, capping, printing and enameling machine
US4663290A (en) * 1982-01-21 1987-05-05 Molecular Genetics, Inc. Production of reverse transcriptase
US5073484A (en) 1982-03-09 1991-12-17 Bio-Metric Systems, Inc. Quantitative analysis apparatus and method
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US4746508A (en) 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US4759376A (en) * 1984-05-29 1988-07-26 Nils Stormby Endocervical sampling brush and smear method
DK8601218A (de) 1984-07-18 1986-03-17
FR2570703B1 (fr) * 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
US4960467A (en) * 1985-02-11 1990-10-02 The United States Of America As Represented By The Secretary Of The Army Dermal substance collection device
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5279943A (en) * 1985-08-02 1994-01-18 Compagnie Oris Industrie Homogeneous process for the detection and/or determination by luminescence of an analyte in a medium in which it may be present
TW203120B (de) 1985-10-04 1993-04-01 Abbott Lab
NL8503596A (nl) 1985-12-31 1987-07-16 Futura Nova Bv Inrichting voor het maken van een uitstrijk van een lichaamsholte.
US4894326A (en) * 1986-04-09 1990-01-16 Fred Hutchinson Cancer Research Center Monoclonal antibody defining oncofetal structure of fibronectin
US5243029A (en) 1986-04-09 1993-09-07 Fred Hutchinson Cancer Research Center Oncofetal structure of fibronectin
US4777128A (en) * 1986-05-27 1988-10-11 Ethigen Corporation Fluorescence immunoassay involving energy transfer between two fluorophores
US5466591A (en) * 1986-08-22 1995-11-14 Hoffmann-La Roche Inc. 5' to 3' exonuclease mutations of thermostable DNA polymerases
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US5455170A (en) * 1986-08-22 1995-10-03 Hoffmann-La Roche Inc. Mutated thermostable nucleic acid polymerase enzyme from Thermus species Z05
US5374553A (en) * 1986-08-22 1994-12-20 Hoffmann-La Roche Inc. DNA encoding a thermostable nucleic acid polymerase enzyme from thermotoga maritima
US4960691A (en) * 1986-09-29 1990-10-02 Abbott Laboratories Chromatographic test strip for determining ligands or receptors
US5132097A (en) 1987-02-11 1992-07-21 G.D. Research Apparatus for analysis of specific binding complexes
US4762133A (en) * 1987-03-20 1988-08-09 Medical Dynamics, Inc. Cervical cytology device
CA1303983C (en) 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
JPS63163167U (de) 1987-04-15 1988-10-25
US5120643A (en) 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US4956302A (en) 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
US5096830A (en) * 1987-11-17 1992-03-17 Adeza Biomedical Corporation Preterm labor and membrane rupture test
CA1337394C (en) 1987-11-17 1995-10-24 Nelson N. H. Teng Vaginal sample test and reagents
US5185270A (en) * 1987-11-17 1993-02-09 Adeza Biomedical Corporation Fetal fibronectin pregnancy test
US5223440A (en) * 1987-11-17 1993-06-29 Adeza Biomedical Corporation Ex vivo product of conception test to determine abortion
DE3741201A1 (de) * 1987-12-02 1989-06-15 Schering Ag Ultraschallarbeitsverfahren und mittel zu dessen durchfuehrung
US5162508A (en) 1987-12-18 1992-11-10 Compagnie Oris Industrie Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
US5209904A (en) * 1987-12-23 1993-05-11 Abbott Laboratories Agglutination reaction device utilizing selectively impregnated porous material
US5244797B1 (en) 1988-01-13 1998-08-25 Life Technologies Inc Cloned genes encoding reverse transcriptase lacking rnase h activity
US5362307A (en) 1989-01-24 1994-11-08 The Regents Of The University Of California Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance
WO1989006989A1 (en) 1988-01-29 1989-08-10 The Regents Of The University Of California Iontophoretic non-invasive sampling or delivery device
US20030232010A2 (en) 1988-03-29 2003-12-18 Immunomedics, Inc. Improved cytotoxic therapy
SE463188B (sv) 1988-05-10 1990-10-22 Stormby Nils Borste foer medicinsk provtagning
US5438984A (en) * 1988-09-08 1995-08-08 Sudor Partners Apparatus and method for the collection of analytes on a dermal patch
US5079171A (en) * 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
US4919889A (en) 1988-09-15 1990-04-24 Aspen Diagnostics Corporation Sample collection and transport fluid composition
US5281522A (en) * 1988-09-15 1994-01-25 Adeza Biomedical Corporation Reagents and kits for determination of fetal fibronectin in a vaginal sample
US5252459A (en) 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
US5236846A (en) * 1988-11-18 1993-08-17 Adeza Biomedical Corporation Ectopic pregnancy test
US5512657A (en) * 1988-12-12 1996-04-30 Bainbridge Sciences, Inc. Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
US5108898A (en) * 1989-01-18 1992-04-28 Peters John H Use of fibronectin having a variable included type III repeat sequence as a marker for toxemia in pregnancy
US5139023A (en) * 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
US5118937A (en) * 1989-08-22 1992-06-02 Finnigan Mat Gmbh Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
US6146657A (en) 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US6713610B1 (en) * 1990-01-12 2004-03-30 Raju Kucherlapati Human antibodies derived from immunized xenomice
US5324280A (en) 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
WO1991016633A1 (en) 1990-04-12 1991-10-31 Adeza Biomedical Corporation Pregnancy induced hypertension and eclampsia immunoassay and reagents
SE465451B (sv) 1990-05-10 1991-09-16 Medscand Ab Instrument foer endo- och ektocervikal provtagning
US5420176A (en) * 1990-06-01 1995-05-30 Imarx Pharmaceutical Corp. Contrast media for ultrasonic imaging
FR2664699B1 (fr) * 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
JP2709311B2 (ja) 1990-09-28 1998-02-04 エフ．ホフマン−ラ ロシュ アクチェンゲゼルシャフト 熱安定性ｄｎａポリメラーゼの５→３′のエキソヌクレアーゼ突然変異
FI86777C (fi) 1990-12-31 1992-10-12 Medix Biochemica Ab Oy Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid
US5198340A (en) * 1991-01-17 1993-03-30 Genentech, Inc. Assay for free igf-i, igf-ii, and gh levels in body fluids
US5211952A (en) 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
FI93607C (fi) 1991-05-24 1995-05-10 John Koivukangas Leikkaustoimenpidelaite
WO1993009432A1 (en) 1991-11-04 1993-05-13 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
EP0642667B1 (de) 1991-11-04 2001-01-10 Adeza Biomedical Corporation Screeningverfahren zur identifizierung von frauen mit erhöhtem frühgeburtsrisiko
US5516702A (en) 1991-11-06 1996-05-14 Adeza Biomedical Corporation Screening method for identifying women at increased risk for imminent delivery
US5270166A (en) 1992-03-30 1993-12-14 Abbott Laboratories Immunoassays employing generic anti-hapten antibodies and materials for use therein
WO1993024836A1 (en) 1992-05-29 1993-12-09 Adeza Biomedical Corporation Screening method for identifying women at increased risk for preterm delivery
WO1993024838A1 (en) 1992-05-29 1993-12-09 Adeza Biomedical Corporation Screening method for identifying women at increased risk for preterm delivery
FI94181C (fi) 1992-06-29 1995-07-25 Medix Biochemica Ab Oy Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
WO1994008238A1 (en) * 1992-09-28 1994-04-14 Biex, Inc. Method for prediction of premature labor
US5491130A (en) * 1992-11-10 1996-02-13 The United States Of America As Represented By The Department Of Health And Human Services Peptide inhibitors of fibronectin and related collagen-binding proteins
EP0680607A4 (de) 1993-01-22 1997-06-04 Adeza Biomedical Corp Testverfahren zur ausschluss von membranrissen als risiko bei kurz vor der entbindung stehenden frauen.
US5395825A (en) 1993-03-10 1995-03-07 Yale University Fertility regulation with transforming growth factor β
US5876978A (en) * 1993-04-06 1999-03-02 Medical College Of Ohio Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
US5500375A (en) * 1993-04-13 1996-03-19 Serex, Inc. Integrated packaging-holder device for immunochromatographic assays in flow-through or dipstick formats
US5645537A (en) * 1993-04-20 1997-07-08 Advanced Cytometrix, Inc. Aspiration needle and syringe for use therewith, apparatus incorporating the same and kit for use in fine needle aspiration cytology, and method
EP0700521B1 (de) * 1993-05-28 2003-06-04 Baylor College Of Medicine Verfahren und massenspektrometer zur desorption und ionisierung von analyten
GB9315847D0 (en) 1993-07-30 1993-09-15 Isis Innovation Tag reagent and assay method
US6056738A (en) 1997-01-31 2000-05-02 Transmedica International, Inc. Interstitial fluid monitoring
US5582184A (en) 1993-10-13 1996-12-10 Integ Incorporated Interstitial fluid collection and constituent measurement
US5370135A (en) * 1993-10-13 1994-12-06 Biex, Inc. Use of estriol measurement to monitor tocolytic therapy
US5650394A (en) * 1993-11-04 1997-07-22 Adeza Biomedical Use of urinastatin-like compounds to prevent premature delivery
US5538897A (en) * 1994-03-14 1996-07-23 University Of Washington Use of mass spectrometry fragmentation patterns of peptides to identify amino acid sequences in databases
ZA95960B (en) * 1994-03-14 1995-10-10 Genetics Inst Use of interleukin-12 antagonists in the treatment of autoimmune diseases
US5523229A (en) 1994-03-22 1996-06-04 Trustees Of The University Of Pennsylvania Antibodies specific for oncofetal fibronectin
US5597700A (en) * 1994-04-28 1997-01-28 California Research, Llc Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
US5658801A (en) 1994-05-03 1997-08-19 Spectral Diagnostics Inc. Medical test kit
US5771890A (en) * 1994-06-24 1998-06-30 Cygnus, Inc. Device and method for sampling of substances using alternating polarity
US5586981A (en) 1994-08-25 1996-12-24 Xin-Hua Hu Treatment of cutaneous vascular and pigmented lesions
US5548158A (en) 1994-09-02 1996-08-20 National Semiconductor Corporation Structure of bipolar transistors with improved output current-voltage characteristics
US6015668A (en) * 1994-09-30 2000-01-18 Life Technologies, Inc. Cloned DNA polymerases from thermotoga and mutants thereof
US5912155A (en) 1994-09-30 1999-06-15 Life Technologies, Inc. Cloned DNA polymerases from Thermotoga neapolitana
US5691151A (en) 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
US5804452A (en) 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
US20030027216A1 (en) * 2001-07-02 2003-02-06 Kiernan Urban A. Analysis of proteins from biological fluids using mass spectrometric immunoassay
US20020164818A1 (en) 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
WO1996037777A1 (en) 1995-05-23 1996-11-28 Nelson Randall W Mass spectrometric immunoassay
US6093541A (en) * 1995-06-07 2000-07-25 Arizona State University Board Of Regents Mass spectrometer having a derivatized sample presentation apparatus
US5656502A (en) 1995-06-07 1997-08-12 Diagnostic Chemicals Limited Test strip holder and method of use
US6004770A (en) 1995-06-07 1999-12-21 Arizona State University Board Of Regents Sample presentation apparatus for mass spectrometry
US6316266B1 (en) * 1995-06-07 2001-11-13 Arizona State University Board Of Regents Sample presentation apparatus for mass spectrometry
US6632976B1 (en) 1995-08-29 2003-10-14 Kirin Beer Kabushiki Kaisha Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
GB9518429D0 (en) 1995-09-08 1995-11-08 Pharmacia Biosensor A rapid method for providing kinetic and structural data in molecular interaction analysis
US6624882B2 (en) 1995-09-08 2003-09-23 Integ, Inc. Methods of sampling body fluid
US5879367A (en) 1995-09-08 1999-03-09 Integ, Inc. Enhanced interstitial fluid collection
WO1997009451A1 (en) 1995-09-08 1997-03-13 Life Technologies, Inc. Cloned dna polymerases from thermotoga and mutants thereof
US5989409A (en) 1995-09-11 1999-11-23 Cygnus, Inc. Method for glucose sensing
DE69700902T2 (de) 1996-01-23 2000-07-20 Rapigene, Inc. Verfahren zur erkennung von ligandenpaar bindung mit erhöter empfindlichkeit
US6678669B2 (en) * 1996-02-09 2004-01-13 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
US6027939A (en) * 1996-03-08 2000-02-22 Universidad De Las Islas Baleares Process for evaluating the global capacity of urine to form chalky renal calculus, and corresponding kit
US5808300A (en) 1996-05-10 1998-09-15 Board Of Regents, The University Of Texas System Method and apparatus for imaging biological samples with MALDI MS
US6005113A (en) 1996-05-15 1999-12-21 Molecular Probes, Inc. Long wavelength dyes for infrared tracing
GB9610967D0 (en) 1996-05-24 1996-07-31 Cambridge Antibody Tech Specific binding members,materials and methods
US6449562B1 (en) * 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
EP0963443B1 (de) 1996-12-10 2006-03-08 Sequenom, Inc. Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung
JP3884087B2 (ja) 1997-01-15 2007-02-21 イクスツィリオン ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 質量標識結合ハイブリダイゼーションプローブ
US6017703A (en) * 1997-03-06 2000-01-25 Bard Diagnostic Sciences, Inc. Methods and compositions for screening for or modulating a tumor associated antigen
EP0975806B1 (de) * 1997-04-03 2006-06-21 Invitrogen Corporation Zusammensetzungen und verfahren der reversen transkriptase-polymerasekettenreaktion (rt-pcr)
AU7023798A (en) * 1997-04-30 1998-11-24 De Novo Enzyme Corporation Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
US6156546A (en) 1997-05-16 2000-12-05 Washington State University Research Foundation Identification and molecular cloning of a gene encoding a fibronectin binding protein (CadF) from Campylobacter coli and Campylobacter jejuni
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US5964735A (en) 1997-07-01 1999-10-12 Medisys Technologies, Inc. Fine needle aspiration safety syringe
US5897840A (en) * 1997-07-16 1999-04-27 Battelle Memorial Institute Multi-chambered urine specimen container for automatic extraction and high forensic integrity
US6436721B1 (en) 1997-07-25 2002-08-20 Bayer Corporation Device and method for obtaining clinically significant analyte ratios
US6503198B1 (en) 1997-09-11 2003-01-07 Jack L. Aronowtiz Noninvasive transdermal systems for detecting an analyte obtained from or underneath skin and methods
US6168779B1 (en) * 1997-09-16 2001-01-02 The Regents Of The University Of California Methods and kits for identifying ductal orifices
US6221622B1 (en) * 1998-04-28 2001-04-24 The Regents Of The University Of California Method and kit for obtaining fluids and cellular material from breast ducts
DE19754978C2 (de) 1997-12-11 2000-07-13 Bruker Daltonik Gmbh Probenträger für die MALDI-Massenspektrometrie nebst Verfahren zur Herstellung der Platten und zum Aufbringen der Proben
US6844158B1 (en) 1997-12-22 2005-01-18 Hitachi Chemical Co., Ltd. Direct RT-PCR on oligonucleotide-immobilized PCR microplates
EP1045714A1 (de) 1998-01-08 2000-10-25 Sontra Medical, L.P. Sonophoretisch verstärkter transdermaler transport
US6265715B1 (en) * 1998-02-02 2001-07-24 Helene Perreault Non-porous membrane for MALDI-TOFMS
US6394952B1 (en) * 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
US6267722B1 (en) * 1998-02-03 2001-07-31 Adeza Biomedical Corporation Point of care diagnostic systems
US6173202B1 (en) 1998-03-06 2001-01-09 Spectrx, Inc. Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue
US6368873B1 (en) * 1998-04-09 2002-04-09 Applied Biotech, Inc. Identification of human urine for drug testing
US6723564B2 (en) 1998-05-07 2004-04-20 Sequenom, Inc. IR MALDI mass spectrometry of nucleic acids using liquid matrices
US20030045681A1 (en) * 1998-05-11 2003-03-06 Anthony J. Zelano Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
US20030176663A1 (en) 1998-05-11 2003-09-18 Eidgenossische Technische Hochscule Specific binding molecules for scintigraphy
CA2335976A1 (en) 1998-06-24 1999-12-29 Transderm Diagnostics, Inc. Non-invasive transdermal detection of analytes
US6168785B1 (en) * 1998-07-16 2001-01-02 Institut Pasteur Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents
DE19834070B4 (de) 1998-07-29 2007-02-15 Bruker Daltonik Gmbh Ionisierung hochmolekularer Substanzen durch Laserdesorption aus flüssigen Matrices
US6670194B1 (en) 1998-08-25 2003-12-30 University Of Washington Rapid quantitative analysis of proteins or protein function in complex mixtures
JP2002524120A (ja) 1998-09-04 2002-08-06 パウダージェクト リサーチ リミテッド 粒子送達法を使用するモニタリング方法
US6620123B1 (en) 1999-12-17 2003-09-16 Sontra Medical, Inc. Method and apparatus for producing homogenous cavitation to enhance transdermal transport
US6638727B1 (en) * 1999-01-26 2003-10-28 Cytyc Health Corporation Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
US6702791B1 (en) 1999-02-04 2004-03-09 Integ, Inc. Needle for body fluid tester
EP1047108B1 (de) 1999-04-06 2006-03-08 Micromass UK Limited Verfahren zur Identifizierung von Peptidensequenzen und Proteinensequenzen mittels Massenspektromterie
US6716636B1 (en) * 1999-04-20 2004-04-06 Target Discovery, Inc. Methods for sequencing proteins
US6342219B1 (en) * 1999-04-28 2002-01-29 Board Of Regents, The University Of Texas System Antibody compositions for selectively inhibiting VEGF
US6334851B1 (en) * 1999-05-10 2002-01-01 Microfab Technologies, Inc. Method for collecting interstitial fluid from the skin
US6642009B2 (en) * 1999-05-17 2003-11-04 Cytyc Health Corporation Isolated ductal fluid sample
DK1189660T3 (da) 1999-06-08 2006-08-21 Altea Therapeutics Corp Apparat til mikroperforering af biologiske membraner ved hjælp af tyndfilms-vævsgrænseflade-anordninger samt fremgangsmåde til fremstilling deraf
US6685699B1 (en) * 1999-06-09 2004-02-03 Spectrx, Inc. Self-removing energy absorbing structure for thermal tissue ablation
US6312612B1 (en) 1999-06-09 2001-11-06 The Procter & Gamble Company Apparatus and method for manufacturing an intracutaneous microneedle array
US6174287B1 (en) * 1999-06-11 2001-01-16 Acuson Corporation Medical diagnostic ultrasound system and method for continuous M-mode imaging and periodic imaging of contrast agents
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US6323186B1 (en) 1999-09-17 2001-11-27 Molecular Probes, Inc. Phosphate-bound polyazaindacene derivatives of nucleotides
GB9929272D0 (en) * 1999-12-10 2000-02-02 Diagnology Limited Assay
AU2088301A (en) * 1999-12-16 2001-06-25 Alza Corporation Device for enhancing transdermal flux of sampled agents
CA2400074A1 (en) 2000-02-18 2001-08-23 William I. Higuchi Methods for extracting substances using alternating current
GB0006141D0 (en) 2000-03-14 2000-05-03 Brax Group Ltd Mass labels
US6690976B2 (en) 2000-04-13 2004-02-10 Celsion Corporation Thermotherapy method for treatment and prevention of breast cancer and cancer in other organs
WO2001083816A2 (en) 2000-05-04 2001-11-08 Philogen S.R.L. Method for detecting tumors
US20020037265A1 (en) * 2000-06-08 2002-03-28 David Hung Preparation for breast duct fluid collection
US6706032B2 (en) * 2000-06-08 2004-03-16 Massachusetts Institute Of Technology Localized molecular and ionic transport to and from tissues
US6409679B2 (en) * 2000-06-13 2002-06-25 Pacific Paragon Investment Fund Ltd. Apparatus and method for collecting bodily fluid
US20030232399A1 (en) 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
JP3816308B2 (ja) 2000-06-19 2006-08-30 ユニ・チャーム株式会社 使い捨ておむつ
JP2004512262A (ja) * 2000-06-20 2004-04-22 アイデック　ファーマスーティカルズ　コーポレイション 非放射性抗ｃｄ２０抗体／放射標識抗ｃｄ２２抗体の組合せ
US6589173B1 (en) 2000-07-17 2003-07-08 The Regents Of The University Of California Ultrasound system for disease detection and patient treatment
JP2004505278A (ja) * 2000-07-28 2004-02-19 シーワイティーワイシー　ヘルス　コーポレイション 乳管洗浄によって回収した乳管上皮細胞の細胞学的評価
US20020013539A1 (en) * 2000-07-28 2002-01-31 David Hung Methods and devices for diagnosis of precancer and cancer in breast milk ducts
EP1307746B1 (de) * 2000-08-08 2007-04-18 Cytyc Corporation Nachweis viraler agentien in brustmilchkanälen und antivirale therapie
IT1317108B1 (it) 2000-12-06 2003-05-26 Philogen Srl Processo per la selezione di frammenti anticorporali anti-angiogenesi,frammenti anticorpali anti-angiogenesi cosi' ottenuti e loro uso.
ATE366936T1 (de) 2001-01-18 2007-08-15 Univ Michigan Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
US6783672B2 (en) * 2001-01-18 2004-08-31 Kemmons A. Tubbs Integrated high throughput system for the mass spectrometry of biomolecules
US6756200B2 (en) * 2001-01-26 2004-06-29 The Johns Hopkins University School Of Medicine Aberrantly methylated genes as markers of breast malignancy
US6657191B2 (en) 2001-03-02 2003-12-02 Bruker Daltonics Inc. Means and method for multiplexing sprays in an electrospray ionization source
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
US7056663B2 (en) * 2001-03-23 2006-06-06 California Pacific Medical Center Prognostic methods for breast cancer
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
WO2002101075A2 (en) * 2001-06-13 2002-12-19 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
US20030003588A1 (en) * 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
WO2003007944A1 (en) * 2001-07-20 2003-01-30 Qlt, Inc. Treatment of macular edema with photodynamic therapy
US6884605B2 (en) * 2001-08-09 2005-04-26 Board Of Trustees Of The University Of Arkansas Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer
WO2003020115A2 (en) 2001-08-31 2003-03-13 Amplistar Inc. Methods and compositions for the detection of cancer
US6630454B2 (en) * 2001-09-10 2003-10-07 Ramot At Tel-Aviv University Ltd. Method and pharmaceutical composition for the treatment of cancer
AU2002329570A1 (en) * 2001-10-12 2003-01-30 Pfizer Products Inc. Method of monitoring neuroprotective treatment
GB0125764D0 (en) * 2001-10-26 2001-12-19 Univ London Diagnosis of cervicasl cancer
US20030138823A1 (en) * 2001-11-05 2003-07-24 Irm, Llc Sample preparation methods for maldi mass spectrometry
US7094549B2 (en) * 2001-11-23 2006-08-22 Syn X Pharma, Inc. Fibronectin biopolymer marker indicative of insulin resistance
US20030104483A1 (en) * 2001-11-30 2003-06-05 Boehringer Ingelheim Pharmaceuticals, Inc. Liquid chromatography/fourier-transform mass spectrometry/electron capture dissociation for the analysis of proteins
US20030186246A1 (en) 2002-03-28 2003-10-02 Willey James C. Multiplex standardized reverse transcriptase-polymerase chain reacton method for assessment of gene expression in small biological samples
JP4267865B2 (ja) 2002-04-19 2009-05-27 株式会社デンソー 負荷駆動装置
US20060166295A1 (en) 2002-07-01 2006-07-27 James Woods Method for determination of likelihood of occurrence of preterm labor in pregnant females
US20040266025A1 (en) * 2003-02-06 2004-12-30 Durlin Hickok Screening and treatment methods for prevention of preterm delivery
JP2008514900A (ja) 2004-07-30 2008-05-08 アデザ・バイオメデイカル・コーポレイシヨン 疾病および他の状態のマーカーとしての癌胎児性フィブロネクチンならびに癌胎児性フィブロネクチンの検出のための方法

Also Published As

Publication number Publication date
WO2006026020A3 (en) 2007-08-16
WO2006026020A2 (en) 2006-03-09
US8372581B2 (en) 2013-02-12
AU2011201303A1 (en) 2011-04-07
EP1778874B1 (de) 2011-11-23
US20060024757A1 (en) 2006-02-02
DK2299275T3 (en) 2018-05-07
CA2575675A1 (en) 2006-03-09
US20060024725A1 (en) 2006-02-02
WO2006026020A9 (en) 2006-07-06
US7943294B2 (en) 2011-05-17
EP2299275A3 (de) 2011-08-03
JP2008514900A (ja) 2008-05-08
EP2299275B1 (de) 2018-03-07
EP1778874A2 (de) 2007-05-02
NZ582466A (en) 2011-09-30
AU2005280528A1 (en) 2006-03-09
US8852872B2 (en) 2014-10-07
AU2011201303B2 (en) 2012-07-26
US20120040356A1 (en) 2012-02-16
HK1103527A1 (en) 2007-12-21
US20060024724A1 (en) 2006-02-02
US20060024722A1 (en) 2006-02-02
AU2005280528B2 (en) 2010-12-23
EP2299275A2 (de) 2011-03-23
US20150044708A1 (en) 2015-02-12
JP2011039068A (ja) 2011-02-24
US20060024723A1 (en) 2006-02-02
US9513298B2 (en) 2016-12-06
US20130171672A1 (en) 2013-07-04

Similar Documents

Publication Publication Date Title
ATE534750T1 (de) Onkofetales fibronektin als zervixkarzinom-marker
EA201000689A1 (ru) Полупроводниковая полимерная композиция
EP1491897A3 (de) Automatischer Analysator
EP2042867A4 (de) Verfahren, vorrichtung und programm zur bewertung der immunität sowie datenaufzeichnungsmedium mit darin gespeichertem immunitätsbewertungsprogramm
WO2008064131A3 (en) Device and process for unique internet access identification
NO20081165L (no) Maler med multinivabruker interfase
WO2007082308A3 (en) Determining relevance of electronic content
WO2006004797A3 (en) Methods and systems for feature selection
EA200701804A1 (ru) Мутации рецептора эпидермального фактора роста
MA32629B1 (fr) Anticorps anti-il-12/il -23
DE602005025805D1 (de) Stabilisierte polymer-thiol-reagenzien
CY1116147T1 (el) Μεθοδος για την ταυτοποιηση ενος υποκειμενου που κινδυνευει να παρουσιασει καρδιακη ανεπαρκεια, μεσω του προσδιορισμου του επιπεδου γαλεκτινης-3 ή θρομβοσπονδινης-2
NO20044231L (no) Innretning for hoyde- og helningskompenasjon
PT1982178E (pt) Métodos para o tratamento de distúrbios afectivos
ATE469986T1 (de) Senp1 als krebsmarker
DE602006016075D1 (de) Wintererholungsvorrichtung
ITMI20041251A1 (it) Gel di perfluoroelastomeri
DK1853735T3 (da) Fremgangsmåder til detektering af progressionen af cervikal dysplasi i let grad
EP2255388A4 (de) Informationsaufzeichnungsvorrichtung und informationsaufzeichnungs-/wiedergabesystem damit
ATE330037T1 (de) Verfahren zur altersbestimmung von individuen
DE60019669D1 (de) Verfahren zum Identifizieren eines Dokuments
NO20010509L (no) Endogene kontitutivt aktiverte G-proteinkoblede "foreldreløse" reseptorer
WO2004027094A3 (en) Assay for camp based on exclusive binding of camp to the b-binding sites of camp dependent protein kinase (capk)
CN204164883U (zh) 一种路用多功能路灯
TW200614163A (en) An reproducing device for record of an optical disc and a distinguishing method thereof